Pcr Based Test Articles & Analysis
20 news found
In the past year miDiagnostics has been working on the development of an ultra-fast PCR test based on imec technology, to detect COVID-19, with a test result in less than 15 minutes. ...
The project will utilize a new, first-of-its-kind PCR diagnostic device, the Sexual Health Click Test, that detects three of the most common and curable STIs in women – gonorrhea, chlamydia and trichomoniasis – in less than 30 minutes. ...
With the launch of its first product, miDiagnostics enters the commercial phase, marking an important milestone in the company’s development. Ultra-fast and reliable COVID testing on a micro-chip miDiagnostics’ COVID-19 PCR Test is based on unique silicon chip technology from imec (Leuven, Belgium) and developed in ...
Visby Medical™, a leading medical diagnostic company, today announced that it has received an additional $25.5M in federal funding to develop and validate an at-home combination Flu-Covid test from the Biomedical Advanced Research and Development Authority (BARDA).The developmental-stage Flu-COVID PCR Test is a single-use, handheld, ...
Anavasi Diagnostics announced today that it has submitted the required EUA Clinical Study Data for the AscencioDx®, the molecular diagnostic platform for the detection of RNA indicative of the presence of the SARS-CoV-2/COVID-19 virus, to the Food and Drug Administration (FDA). Anavasi is a medical technology company focused on the development of novel molecular diagnostic testing. It uses a ...
Based on its technology and easy-to-perform test procedure, the AscencioDx has potential for at-home use pending further clinical validation and FDA clearance. ...
” About Bladder EpiCheck® Bladder EpiCheck provides patients and clinicians with a simple, objective urine test to detect recurrence of bladder tumors. The test analyzes subtle disease-specific changes in DNA methylation markers, allowing for the detection of 92% of the high-risk (non Ta-LG) cancers. ...
” About Bladder EpiCheck® Bladder EpiCheck provides patients and clinicians with a simple, objective urine test to detect recurrence of bladder tumors. The test analyzes subtle disease-specific changes in DNA methylation markers, allowing for the detection of 92% of the high-risk (non Ta-LG) cancers. ...
According to the results, the Lumex Instruments’ COVID-19 test kit provides accurate and reliable results in 30 minutes with 10 times fewer reagents spent than tube-based PCR tests. “So it’s 10 times less expensive, roughly speaking”, said Peter Unrau, an SFU molecular biology and biochemistry professor in ...
The first round of testing began today and continues through the end of the school year. ...
Unfortunately, rapid COVID-19 tests often have limited accuracy, while reliable diagnostic tests, based on PCR analysis and performed in central laboratories, can take anywhere from several hours to several days from a sample collection to a test result. miDiagnostics has developed a unique solution: an ...
Mesa Biotech has developed the Accula System, an affordable, easy-to-use, point-of-care PCR-based testing platform for infectious disease diagnosis. The platform enables rapid, highly accurate testing at physician offices, pharmacies and other settings, providing results in 30 minutes. Beyond COVID-19 testing, ...
Mesa Biotech has developed and commercialized a PCR-based rapid point-of-care testing platform available for detecting infectious diseases including SARS-CoV-2, Influenza A and B, respiratory syncytial virus (RSV) and Strep A. Mesa Biotech's patented technology expands the availability of gold standard nucleic acid PCR ...
Thermo Fisher Scientific announced today the availability of a new direct from saliva PCR test for COVID-19 to enable widespread, high-frequency surveillance testing. ...
About Bladder EpiCheck® Bladder EpiCheck provides patients and clinicians with a simple, objective urine test to detect recurrence of bladder tumors. The test analyzes subtle disease-specific changes in DNA methylation markers, allowing for the detection of 92% of the high-grade (non Ta-LG) cancers. ...
The test arrived in the mail in early November. I took it on a Wednesday, then mailed off my sample to Vienna for processing. On Friday, I received an email with a link to my results: negative. I didn’t have the symptoms anyway, apart from fatigue—a common symptom of having an early rising toddler—but given the fact that many carriers remain asymptomatic, it was good to confirm ...
(NYSE:TMO), the world leader in serving science, announced it has received an expansion of its Emergency Use Authorization (EUA) for the TaqPath COVID-19 Combo Kit to include an additional sample collection method provided by Everlywell, a leading digital health testing company. The TaqPath test is authorized for use with the Everlywell COVID-19 ...
(NYSE: TMO), the world leader in serving science, today introduced two new SARS-CoV-2 antibody tests: the Thermo Scientific OmniPATH COVID-19 Total Antibody ELISA test, and the Thermo Scientific EliA SARS-CoV-2-Sp1 IgG test. ...
(NYSE: TMO), the world leader in serving science, announced it will expand its response to the COVID-19 pandemic by developing a total antibodies test in collaboration with WuXi Diagnostics and Mayo Clinic. The new test is the result of ongoing collaboration between all three organizations, including clinical evaluation and support from Mayo Clinic. ...
Millions of people have been tested for the novel coronavirus, most using a kit that relies on the polymerase chain reaction (PCR). ...